FDA Warns of Serious Liver Injury Risk with Mavyret, Zepatier, and Vosevi in Advanced Liver Disease
FDA reports rare cases of worsening liver function or liver failure in patients with advanced liver disease treated with Mavyret, Zepatier, or Vosevi.